At the Anuga FoodTec trade show in Cologne, Germany on March 19-22, 2024, GEA Group unveiled their new perfusion platform. This technology is a game-changer for cutting-edge upstream bioprocesses that enable continuous processing in cell cultivation and precision fermentation. Through this process, cells from the Axenic bioreactor are separated from the nutrient solution containing inhibitors using the kytero single-use separator. This separation process enhances the density of living cells and ultimately boosts productivity.
The technology presented at the trade show shows promise for reprocessing media, which is a significant cost factor in new-food production and can affect final products. By utilizing this perfusion platform, companies in the new-food industry can increase productivity and potentially reduce costs associated with media reprocessing. The advancements made in this technology highlight the innovative solutions being developed in the field of bioprocesses and biotechnology.
GEA Group, based in Düsseldorf, Germany, is committed to improving efficiency and productivity in new-food production through state-of-the-art technologies like their perfusion platform. Their presence at Anuga FoodTec underscores their dedication to sharing knowledge and innovations with industry professionals and stakeholders.
Overall, GEA Group’s perfusion platform offers exciting potential for new-food production while demonstrating their commitment to advancing bioprocesses and cell cultivation. Their participation at Anuga FoodTec highlights their ongoing efforts to shape the future of these fields.
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/37GBLO5SNRHBBKFLCSNJ4KWJ54.jpg)
